The results of these studies are as follows: Weight loss with semaglutide occurs gradually over time and sustainable weight loss requires patience
So even if GLP-1 has no effect on these businesses, its hard to see how these stocks materially outperform the market from here given those starting multiples

acting upon different organs such as the pancreatic islets, the hypothalamus or the stomach, for the release of insulin, to regulate food intake or gastric emptying respectively ( Surprisingly, this heterogeneous and highly plastic population of cells is known to differentiate from a single staminal progenitor that gives also rise to enterocytes, goblet and paneth cells ( It has been known for more than a century that the gut is capable to stimulate the endocrine portion of the pancreas and even improve the hyperglycaemic state of diabetic patients ( In the last three decades, the incretin-effect has been attributed primarily to two peptide hormones, the gastric-insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1), excreted primarily by duodenal (K) and ileo-colonic (L) enteroendocrine cells respectively ( Obesity and Type 2 diabetes are chronic diseases for which the most effective treatment is bariatric surgery

mean BMI, 41.3 kg/m 2 ) with overweight (n = 5) or obesity with data on semaglutide (Wegovy, Novo Nordisk) use collected between January 2021 and March 2022
Go to the bathroom as part of your bedtime routine
These products may not undergo the same rigorous quality control as FDA-approved medications